An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerance of multiple intravenous
(through a vein) doses of trodusquemine (MSI-1436) in obese or overweight, type 2 diabetics.